New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)

Summary

The FDA's Adverse Event Monitoring System has identified potential signals of serious risks and new safety information from adverse event reports. This is a general informational update about FDA safety monitoring procedures without specific drug or company details.